Back to Search
Start Over
Impact of <scp>SARS‐CoV‐</scp> 2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population‐based retrospective cohort study
- Source :
- BJOG: An International Journal of Obstetrics and Gynaecology, BJOG: An International Journal of Obstetrics and Gynaecology, 2022, 129 (7), pp.1084-1094. ⟨10.1111/1471-0528.17135⟩
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
-
Abstract
- To determine the impact of maternal coronavirus disease 2019 (COVID-19) on prematurity, birthweight and obstetric complications.Nationwide, population-based retrospective cohort study.National Programme de Médicalisation des Systèmes d'Information database in France.All single births from March to December 2020: 510 387 deliveries, including 2927 (0.6%) with confirmed COVID-19 in the mother and/or the newborn.The group with COVID-19 was compared with the group without COVID-19 using the chi-square test or Fisher's exact test, and the Student's t test or Mann-Whitney U test. Logistic regressions were used to study the effect of COVID-19 on the risk of prematurity or macrosomia (birthweight ≥4500 g).Prematurity less than 37, less than 28, 28-31, or 32-36 weeks of gestation; birthweight; obstetric complications.In singleton pregnancies, COVID-19 was associated with obstetric complications such as hypertension (2.8% versus 2.0%, p 0.01), pre-eclampsia (3.6% versus 2.0%, p 0.01), diabetes (18.8% versus 14.4%, p 0.01) and caesarean delivery (26.8% versus 19.7%, p 0.01). Among pregnant women with COVID-19, there was more prematurity between 28 and 31 weeks of gestation (1.3% versus 0.6%, p 0.01) and between 32 and 36 weeks of gestation (7.7% versus 4.3%, p 0.01), and more macrosomia (1.0% versus 0.7%, p = 0.04), but there was no difference in small-for-gestational-age newborns (6.3% versus 8.7%, p = 0.15). Logistic regression analysis for prematurity showed an adjusted odds ratio (aOR) of 1.77 (95% CI 1.55-2.01) for COVID-19. For macrosomia, COVID-19 resulted in non-significant aOR of 1.38 (95% CI 0.95-2.00).COVID-19 is a risk factor for prematurity, even after adjustment for other risk factors.The risk of prematurity is twice as high in women with COVID-19 after adjustment for factors usually associated with prematurity.
- Subjects :
- [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
hypertension
pre-eclampsia
SARS-CoV-2
prematurity
Infant, Newborn
COVID-19
Obstetrics and Gynecology
[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
Fetal Macrosomia
Cohort Studies
small for gestational age
[SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
Pregnancy
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Multivariate Analysis
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Birth Weight
Humans
Female
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Pregnancy Complications, Infectious
Retrospective Studies
Subjects
Details
- ISSN :
- 14710528 and 14700328
- Volume :
- 129
- Database :
- OpenAIRE
- Journal :
- BJOG: An International Journal of Obstetrics & Gynaecology
- Accession number :
- edsair.doi.dedup.....2c97bf78c6bd1876577ce8e0701fba4d
- Full Text :
- https://doi.org/10.1111/1471-0528.17135